Epidemiological study of childhood-onset systemic sclerosis and localized scleroderma
Not Applicable
- Conditions
- Systemic sclerosis Localized scleroderma
- Registration Number
- JPRN-UMIN000044578
- Lead Sponsor
- The study group for "Diagnostic criteria, severity classification, guideline, patient registry of systemic sclerosis and cutaneous fibrotic diseases"
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
Persons who are judged to be ineligible for this study by the principal investigator.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The prevalence of patients with childhood-onset systemic sclerosis and localized scleroderma in Japan.
- Secondary Outcome Measures
Name Time Method Clinical features of patients with childhood-onset systemic sclerosis and localized scleroderma.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are implicated in childhood-onset systemic sclerosis and localized scleroderma according to recent epidemiological studies?
How do standard-of-care treatments for pediatric systemic sclerosis compare in efficacy and safety with emerging therapies like tyrosine kinase inhibitors?
Which biomarkers are associated with disease severity and progression in childhood-onset localized scleroderma as identified in patient registries?
What are the most common adverse events in pediatric systemic sclerosis patients and how are they managed in clinical practice?
What novel drug targets are being explored for fibrosis in systemic sclerosis and localized scleroderma based on recent research?